← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	% of Portfolio	Status
2076	CCM Cobalt Capital Management Short Hills, New Jersey	$0	-$40.3M	–	Closed
2077	CCM Conatus Capital Management Greenwich, Connecticut	$0	-$86M	–	Closed
2078	CA Corrado Advisors Ramsey, New Jersey	$0	-$261K	–	Closed
2079	Davidson Kempner Capital Management New York	$0	-$14.4M	–	Closed
2080	EI EDMP Inc Lutz, Florida	$0	-$221K	–	Closed
2081	EMA Efficient Market Advisors San Diego, California	$0	-$1K	–	Closed
2082	EWM Elite Wealth Management Kirkland, Washington	$0	-$89K	–	Closed
2083	EA Elm Advisors Burlingame, California	$0	-$214K	–	Closed
2084	EC Eminence Capital New York	$0	-$15.4M	–	Closed
2085	ECM Ensemble Capital Management San Francisco, California	$0	-$3.53M	–	Closed
2086	FNYS First New York Securities New York	$0	-$863K	–	Closed
2087	Flow Traders U.S. New York	$0	-$699K	–	Closed
2088	FCM Freshford Capital Management Rye Brook, New York	$0	-$16.6M	–	Closed
2089	FIG Fusion Investment Group Pittsburgh, Pennsylvania	$0	-$55K	–	Closed
2090	GC Greenlight Capital New York	$0	-$3.67M	–	Closed
2091	GP Grow Partners San Diego, California	$0	-$2.47M	–	Closed
2092	Hennessy Advisors Inc Novato, California	$0	-$263K	–	Closed
2093	HCM Hodges Capital Management Dallas, Texas	$0	-$316K	–	Closed
2094	HCM Hollencrest Capital Management Newport Beach, California	$0	-$148K	–	Closed
2095	HCM Hoplite Capital Management New York	$0	-$105M	–	Closed
2096	Institutional Capital Chicago, Illinois	$0	-$76.8M	–	Closed
2097	IAM Integre Asset Management New York	$0	-$11.5M	–	Closed
2098	IAA Ironsides Asset Advisors Rocky Mount, North Carolina	$0	-$368K	–	Closed
2099	Jasper Ridge Partners Menlo Park, California	$0	-$755K	–	Closed
2100	JGC J. Goldman & Co New York	$0	-$591K	–	Closed